Every cancer is unique, and treatments are not one-size-fits-all. Precision Oncology (genomic medicine) treats patients with care tailored to genetic information by prescribing the most effective methods. Individualized care is determined by how you will best respond to treatment.
Did you know?
Avera partners with the Worldwide Innovative Networking (WIN) Consortium. This global network includes leading medical, academic, industry, insurance and non-profit research organizations transforming targeted therapies based on the science of genomics. Learn More
Precisely Targeted Treatment
At the Avera Cancer Institute, we use multiple tests and advanced technologies to effectively diagnose and treat your cancer. Since accuracy and timing are critical to treating cancer, we strive to provide you with the right answers as quickly as possible.
Patient-Focused Approach
At Avera, we recognize each tumor is unique – and therefore, each treatment plan is uniquely designed to target your specific cancer. Genomic testing helps us determine which molecular changes are driving growth of the tumor. That's why comprehensive molecular profiling (DNA, RNA and other protein information) takes place at diagnosis to steer treatment options, such as multi-drug combinations to block various paths limiting tumor growth.
Dedicated Genomics Experts
Avera’s Precision Oncology team collaborates with physicians to prioritize what alterations are driving the cancer. They also work with leading experts in genomics and translational research to advance therapies in hopes of finding a cure. This includes bioinformatics experts, interventional radiologists, pathologists, research scientists, among others.
